A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood

Therapeutic Drug Monitoring

Volumn 30, Issue 3, 2008, Pages 292-300

  Salm, Paul ^a   Taylor, Paul J ^a   Rooney, Frank ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b Applied Biosystems   (Australia)

Author keywords

Cyclosporin; High performance liquid chromatography mass spectrometry; Tacrolimus; Therapeutic drug monitoring; Transplantation

Indexed keywords

ACETONITRILE; ASCOMYCIN; CYCLOSPORIN A; CYCLOSPORIN D; EVEROLIMUS; MYCOPHENOLIC ACID; PROTEIN; RAPAMYCIN; TACROLIMUS; ZINC SULFATE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ACCURACY; ARTICLE; ATMOSPHERIC PRESSURE; BLOOD SAMPLING; CLINICAL ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IONIZATION; MASS SPECTROMETRY; MONITORING; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; TANDEM MASS SPECTROMETRY; BLOOD; REPRODUCIBILITY; STANDARD;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MASS SPECTROMETRY; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TACROLIMUS;

EID: 47249130731     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181771feb     Document Type: Article

References (44)

1. Shaw LM, Holt DW, Keown P, et al. Current opinions on therapeutic drug monitoring of immunosuppressive drugs. Clin Ther. 1999;21:1632-1652.
2. Armstrong VW, Oellerich M. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem. 2001;34:9-16.
3. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin Chem. 1999;45: 371-381.
4. Cogill JL, Taylor PJ, Westley IS, et al. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem. 1998;44:1942-1946.
5. Westley IS, Taylor PJ, Salm P, et al. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients. Ther Drug Monit. 2007;29: 584-591.
6. Akbas SH, Ozdem S, Caglar S, et al. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods. Clin Biochem. 2005;38: 552-557.
7. Brown NW, Gonde CE, Adams JE, et al. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry. Clin Chem. 2005;51:586-592.
8. Tomita T, Homma M, Yuzawa K, et al. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring. Ther Drug Monit. 2005;27:94-97.
9. Armendariz Y, Garcia S, Lopez RM, et al. Hematocrit influences immunoassay performance for the measurement of tacrolimus in whole blood. Ther Drug Monit. 2005;27:766-769.
10. Cooper DP, Napoli KL, Taylor PJ, et al. The MassTraktm reagent kit for tacrolimus quantification by HPLC-MS/MS: a multicentre validation. Ther Drug Monit. 2007;29:508-509.
11. Taylor PJ. Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry. Ther Drug Monit. 2004;26:215-219.
12. Taylor PJ. High-performance liquid chromatography-mass spectrometry in the clinical laboratory. Ther Drug Monit. 2005;27:689-693.
13. Taylor PJ, Jones A, Balderson GA, et al. Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatographyelectrospray tandem mass spectrometry. Clin Chem. 1996;42:279-285.
14. Taylor PJ, Jones CE, Martin PT, et al. Microscale high-performance liquid chromatography-electrospray tandem mass spectrometry assay for cyclosporin A in blood. J Chromatogr B Biomed Sci Appl. 1998;705:289-294.
15. Keevil BG, Tierney DP, Cooper DP, et al. Rapid liquid chromatographytandem mass spectrometry method for routine analysis of cyclosporin A over an extended concentration range. Clin Chem. 2002;48:69-76.
16. Keevil BG, McCann SJ, Cooper DP, et al. Evaluation of a rapid microscale assay for tacrolimus by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem. 2002;39:487-492.
17. Streit F, Armstrong VW, Oellerich M. Rapid liquid chromatographytandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin Chem. 2002;48:955-958.
18. Wallemacq PE, Vanbinst R, Asta S, et al. High-throughput liquid chromatography-tandem mass spectrometric analysis of sirolimus in whole blood. Clin Chem Lab Med. 2003;41:921-925.
19. Bogusz MJ, Enazi EA, Hassan H, et al. Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;850: 471-480.
20. Taylor PJ, Franklin ME, Graham KS, et al. A HPLC-mass spectrometric method suitable for the therapeutic drug monitoring of everolimus. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;848:208-214.
21. Kirchner GI, Vidal C, Jacobsen W, et al. Simultaneous on-line extraction and analysis of sirolimus (rapamycin) and ciclosporin in blood by liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl. 1999;721:285-294.
22. Volosov A, Napoli KL, Soldin SJ. Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass-spectrometry. Clin Biochem. 2001;34:285-290.
23. Deters M, Kirchner G, Resch K, et al. Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS). Clin Chem Lab Med. 2002;40: 285-292.
24. Koal T, Deters M, Casetta B, et al. Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;805: 215-222.
25. Ceglarek U, Lembcke J, Fiedler GM, et al. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta. 2004;346:181-190.
26. Shah VP, Midha KK, Findlay JW, et al. Bioanalytical method validation: a revisit with a decade of progress. Pharm Res. 2000;17:1551-1557.
27. Anon. Guidance for industry. Bioanalytical method validation. Available at: wwwfdagov/cder/guidance/guidancehtm 2001. Accessed November 15, 2007.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
29. King R, Bonfiglio R, Fernandez-Metzler C, et al. Mechanistic investigation of ionization suppression in electrospray ionization. J Am Soc Mass Spectrom. 2000;11:942-950.
30. Saint-Marcoux F, Sauvage FL, Marquet P. Current role of LC-MS in therapeutic drug monitoring. Anal Bioanal Chem. 2007;388:1327-1349.
31. Maurer HH. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem. 2007;388:1315-1325.
32. Taylor PJ, Brown SR, Cooper DP, et al. Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry. Clin Chem. 2005;51:1890-1893.
33. Oellerich M, Armstrong VW, Kahan B, et al. Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit. 1995;17:642-654.
34. Mahalati K, Kahan BD. Clinical pharmacokinetics of sirolimus. Clin Pharmacokinet. 2001;40:573-585.
35. McAlister VC, Peltekian KM, Malatjalian DA, et al. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus. Liver Transpl. 2001;7:701-708.
36. Oellerich M, Armstrong VW. Two-hour cyclosporine concentration determination: an appropriate tool to monitor Neoral therapy? Ther Drug Monit. 2002;24:40-46.
37. Cantarovich M, Barkun JS, Tchervenkov JI, et al. Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients. Transplantation. 1998;66:1621-1627.
38. Belitsky P, Dunn S, Johnston A, et al. Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients. Clin Pharmacokinet. 2000;39:117-125.
39. Brewer E, Henion J. Atmospheric pressure ionization LC/MS/MS techniques for drug disposition studies. J Pharm Sci. 1998;87: 395-402.
40. Schuhmacher J, Zimmer D, Tesche F, et al. Matrix effects during analysis of plasma samples by electrospray and atmospheric pressure chemical ionization mass spectrometry: practical approaches to their elimination. Rapid Commun Mass Spectrom. 2003;17:1950-1957.
41. Souverain S, Rudaz S, Veuthey JL. Matrix effect in LC-ESI-MS and LCAPCI-MS with off-line and on-line extraction procedures. J Chromatogr A. 2004;1058:61-66.
42. McMahon LM, Luo S, Hayes M, et al. High-throughput analysis of everolimus (RAD001) and cyclosporin A (CsA) in whole blood by liquid chromatography/mass spectrometry using a semi-automated 96-well solid-phase extraction system. Rapid Commun Mass Spectrom. 2000; 14:1965-1971.
43. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003;75:3019-3030.
44. Taylor PJ. Matrix effects: the Achilles heel of quantitative highperformance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 2005;38:328-334.